Heitman Real Estate Securities’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-802,397
Closed -$4.07M 59
2025
Q3
$4.07M Buy
802,397
+17,348
+2% +$76.4K 0.28% 43
2025
Q2
$3.38M Sell
785,049
-321,684
-29% -$1.59M 0.24% 43
2025
Q1
$6.67M Sell
1,106,733
-784,585
-41% -$3.97M 0.43% 37
2024
Q4
$7.47M Sell
1,891,318
-164,301
-8% -$736K 0.48% 38
2024
Q3
$12M Sell
2,055,619
-410,349
-17% -$2.02M 0.66% 38
2024
Q2
$10.6M Buy
2,465,968
+1,138,481
+86% +$5.46M 0.67% 35
2024
Q1
$6.24M Sell
1,327,487
-228,669
-15% -$876K 0.36% 37
2023
Q4
$7.64M Sell
1,556,156
-1,872,604
-55% -$9.17M 0.41% 36
2023
Q3
$18.7M Sell
3,428,760
-27,121
-0.8% -$217K 1.12% 30
2023
Q2
$32M Sell
3,455,881
-389,660
-10% -$3.3M 1.76% 20
2023
Q1
$31.6M Buy
3,845,541
+161,321
+4% +$1.78M 1.59% 21
2022
Q4
$41M Buy
3,684,220
+772,265
+27% +$8.98M 2.18% 21
2022
Q3
$34.5M Buy
+2,911,955
New +$44.1M 1.87% 24

Other funds holding MPT

Heitman Real Estate Securities's MPT Position: Q4 2025 in Review

Heitman Real Estate Securities sold out of Medical Properties Trust (MPT) in Q4 2025, closing a stake of 802,397 shares — an estimated $4.07M sold.

Heitman Real Estate Securities first reported a position in MPT in Q3 2022 and held it in 13 quarters. The position peaked at $41M in Q4 2022. 485 funds tracked by Wall St. Rank hold MPT as of Q4 2025.

  • Heitman Real Estate Securities reported no remaining Medical Properties Trust position as of Q4 2025 after selling out during the quarter.
  • Heitman Real Estate Securities sold 802,397 Medical Properties Trust shares in Q4 2025, an estimated $4.07M.
  • Heitman Real Estate Securities first reported a position in Medical Properties Trust in Q3 2022 and held it in 13 quarters.
  • Heitman Real Estate Securities's Medical Properties Trust position peaked at $41M in Q4 2022.
  • 485 funds tracked by Wall St. Rank held Medical Properties Trust as of Q4 2025.

Based on Heitman Real Estate Securities's 13F filing for Q4 2025, filed 13 Feb 2026.